시장보고서

상품코드

1611036

콜레라 백신 시장 규모, 점유율, 분석 보고서 : 유형별, 제품별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Cholera Vaccines Market Size, Share & Analysis Report By Type, By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

발행일: 2024년 11월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

콜레라 백신 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 콜레라 백신 세계 시장 규모는 2030년까지 1억 6,340만 달러에 달할 것으로 예상되며, 2025-2030년 연평균 10.0%의 CAGR을 기록할 것으로 예상됩니다. 콜레라에 대한 이니셔티브 증가와 인식 개선이 시장 성장의 주요 요인입니다.

콜레라로 고통받는 지역의 개발도상국 정부는 강력한 공중 보건 및 위생 인프라를 개발하여 이 질병을 퇴치하기 위해 노력하고 있으며, 2013년 2월 아이티 정부는 10년간의 국가 콜레라 퇴치 계획을 시작했습니다. 유엔기구는 콜레라 퇴치를 유엔의 중요한 우선순위로 삼고 있으며, 48시간 내 경보에 대응할 수 있는 시스템 구축, 가정 방문, 홍보 캠페인 등을 통해 아이티 정부를 지원하고 있습니다.

또한, 아프리카에서는 역학 조사, 인류학 조사 등 다양한 연구 프로젝트와 조사가 진행되고 있습니다. 현재 진행 중인 연구에는 전염병의 확산 메커니즘을 이해하고 발병을 예측하기 위해 물 샘플에서 콜레라균(Vibrio cholerae)을 검출하는 신속 진단 테스트를 사용하는 것이 포함됩니다. 콜레라 플랫폼은 세계 콜레라 대책위원회(GTFCC)의 WASH 작업반과 협력하고 있습니다. 이 단체는 콜레라 질병을 통제하고 예방하기 위한 사례 연구 수행 방법을 개발하는 것을 목표로 하고 있습니다.

콜레라 백신 시장 보고서 하이라이트

콜레라 백신 세계 시장 규모는 2024년 9,390만 달러로 2025-2030년까지 연평균 10.0% 성장할 것으로 예상됩니다.
제품별로는 2024년 Dukoral 백신이 시장을 장악했습니다. 이 우위는 2004 년부터이 백신이 이 질병 예방에 좋은 결과를 가져 왔기 때문에 Dukoral은 안전하고 안정적인 것으로 간주됩니다.
Vaxchora 부문은 1회 접종 및 부작용 감소와 같은 이 백신과 관련된 이점으로 인해 예측 기간 동안 유리한 CAGR을 보일 것으로 예상됩니다.
북미는 2024년 발병률 증가와 질병 및 백신 접종에 대한 인식을 높이기 위한 이니셔티브 증가 등의 요인으로 인해 가장 큰 점유율을 차지했습니다.

지역별 시장 점유율 분석, 2024년과 2030년
지역별 시장 대시보드
시장 규모와 예측 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

참여자 개요
기업의 시장 포지션 분석
기업 분류
전략 매핑
기업 개요/상장 기업
- Valneva SE
- Sanofi SA
- Emergent BioSolutions Inc.
- PaxVax Inc.
- EuBiologics Co., Ltd.
- Shantha BIoTechnics Limited
- Hilleman Laboratories
- Astellas Pharma Inc.
- Incepta Vaccine Ltd.
- VabIoTech

ksm 25.01.03

Cholera Vaccines Market Growth & Trends:

The global cholera vaccines market size is expected to reach USD 163.4 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.0% from 2025 to 2030. Increase in number of initiatives and rising awareness about cholera are major factors contributing toward market growth.

Governments in regions affected by cholera are striving to eliminate the disease by developing a strong public health and sanitation infrastructure. In February 2013, the Government of Haiti launched a 10-year National Cholera Elimination Plan. The United Nations Organization has made elimination of cholera a key UN priority and offers support to the Haitian Government by establishing a mechanism to respond to an alert within 48 hours, household visits, and sensitization campaigns.

Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group. This association aims to develop a method for conducting case studies to control and prevent the disease.

Cholera Vaccines Market Report Highlights:

The global cholera vaccine market size was valued at USD 93.9 million in 2024 and is anticipated to grow at a CAGR of 10.0% from 2025 to 2030
By product, Dukoral vaccine dominated the market in 2024. The dominance can be attributed to the positive outcomes of this vaccine in preventing the disease since 2004. Dukoral is considered to be safe and stable
The Vaxchora segment is expected to exhibit a lucrative CAGR over the forecast period owing to benefits associated with the vaccine, such as single dose immunization and reduced adverse effects
North America held the largest share in 2024 due to factors such as increasing incidence and growing initiatives for raising awareness about the disease and vaccination

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Cholera Vaccine Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Cholera Vaccine Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining Power of the Suppliers
  - 3.4.1.2. Bargaining Power of the Buyers
  - 3.4.1.3. Threats of Substitution
  - 3.4.1.4. Threats from New Entrants
  - 3.4.1.5. Competitive Rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political Landscape
  - 3.4.2.2. Economic and Social Landscape
  - 3.4.2.3. Technological Landscape
  - 3.4.2.4. Environmental Landscape
  - 3.4.2.5. Legal Landscape

Chapter 4. Cholera Vaccine Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Whole Cell V. Cholerae O1 with Recombinant B-subunit
- 4.4.1. Whole Cell V. Cholerae O1 with Recombinant B-subunit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Killed Oral O1 and O139
- 4.5.1. Killed Oral O1 and O139 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cholera Vaccine Market: Product Estimates & Trend Analysis

5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Vaxchora
- 5.4.1. Vaxchora Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Dukoral
- 5.5.1. Dukoral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Shanchol
- 5.6.1. Shanchol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Other Products
- 5.7.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cholera Vaccine Market: Distribution Channel Estimates & Trend Analysis

6.1. Distribution Channel Market Share, 2024 & 2030
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
6.4. Hospital Pharmacy
- 6.4.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Retail Pharmacy
- 6.5.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
- 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cholera Vaccine Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework
  - 7.4.2.3. Competitive Insights
  - 7.4.2.4. U.S. Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework
  - 7.4.3.3. Competitive Insights
  - 7.4.3.4. Canada Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Regulatory Framework
  - 7.4.4.3. Competitive Insights
  - 7.4.4.4. Mexico Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework
  - 7.5.2.3. Competitive Insights
  - 7.5.2.4. UK Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework
  - 7.5.3.3. Competitive Insights
  - 7.5.3.4. Germany Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework
  - 7.5.4.3. Competitive Insights
  - 7.5.4.4. France Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework
  - 7.5.5.3. Competitive Insights
  - 7.5.5.4. Italy Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework
  - 7.5.6.3. Competitive Insights
  - 7.5.6.4. Spain Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Denmark
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Regulatory Framework
  - 7.5.7.3. Competitive Insights
  - 7.5.7.4. Denmark Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Regulatory Framework
  - 7.5.8.3. Competitive Insights
  - 7.5.8.4. Sweden Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Norway
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Regulatory Framework
  - 7.5.9.3. Competitive Insights
  - 7.5.9.4. Norway Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. China
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework
  - 7.6.2.3. Competitive Insights
  - 7.6.2.4. China Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Japan
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework
  - 7.6.3.3. Competitive Insights
  - 7.6.3.4. Japan Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Framework
  - 7.6.4.3. Competitive Insights
  - 7.6.4.4. India Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Framework
  - 7.6.5.3. Competitive Insights
  - 7.6.5.4. Australia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. South Korea
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Framework
  - 7.6.6.3. Competitive Insights
  - 7.6.6.4. South Korea Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Regulatory Framework
  - 7.6.7.3. Competitive Insights
  - 7.6.7.4. Thailand Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework
  - 7.7.2.3. Competitive Insights
  - 7.7.2.4. Brazil Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Framework
  - 7.7.3.3. Competitive Insights
  - 7.7.3.4. Argentina Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework
  - 7.8.2.3. Competitive Insights
  - 7.8.2.4. South Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Regulatory Framework
  - 7.8.3.3. Competitive Insights
  - 7.8.3.4. Saudi Arabia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Regulatory Framework
  - 7.8.4.3. Competitive Insights
  - 7.8.4.4. UAE Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Regulatory Framework
  - 7.8.5.3. Competitive Insights
  - 7.8.5.4. Kuwait Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Valneva SE
  - 8.5.1.1. Participant's Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Recent Developments/ Strategic Initiatives
- 8.5.2. Sanofi S.A.
  - 8.5.2.1. Participant's Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Recent Developments/ Strategic Initiatives
- 8.5.3. Emergent BioSolutions Inc.
  - 8.5.3.1. Participant's Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Recent Developments/ Strategic Initiatives
- 8.5.4. PaxVax Inc.
  - 8.5.4.1. Participant's Overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Recent Developments/ Strategic Initiatives
- 8.5.5. EuBiologics Co., Ltd.
  - 8.5.5.1. Participant's Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Recent Developments/ Strategic Initiatives
- 8.5.6. Shantha Biotechnics Limited
  - 8.5.6.1. Participant's Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Recent Developments/ Strategic Initiatives
- 8.5.7. Hilleman Laboratories
  - 8.5.7.1. Participant's Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Recent Developments/ Strategic Initiatives
- 8.5.8. Astellas Pharma Inc.
  - 8.5.8.1. Participant's Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Recent Developments/ Strategic Initiatives
- 8.5.9. Incepta Vaccine Ltd.
  - 8.5.9.1. Participant's Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Recent Developments/ Strategic Initiatives
- 8.5.10. Vabiotech
  - 8.5.10.1. Participant's Overview
  - 8.5.10.2. Financial Performance
  - 8.5.10.3. Product Benchmarking
  - 8.5.10.4. Recent Developments/ Strategic Initiatives

콜레라 백신 시장 규모, 점유율, 분석 보고서 : 유형별, 제품별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Cholera Vaccines Market Size, Share & Analysis Report By Type, By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

콜레라 백신 시장 성장과 동향

콜레라 백신 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 콜레라 백신 시장 변수, 동향, 범위

제4장 콜레라 백신 시장 : 유형별, 추정·동향 분석

제5장 콜레라 백신 시장 : 제품별, 추정·동향 분석

제6장 콜레라 백신 시장 : 유통 채널별, 추정·동향 분석

제7장 콜레라 백신 시장 : 지역별, 추정·동향 분석